Overview
Lepromatous anterior uveitis, often associated with systemic inflammatory conditions like spondyloarthropathies, particularly ankylosing spondylitis (AS) in HLA-B27 positive individuals, involves inflammation of the anterior segment of the eye, potentially leading to complications such as fibrinous exudation, posterior synechiae, and vitreous opacity 3.Diagnosis
Key Diagnostic Criteria: Presence of anterior segment inflammation, often unilateral or alternating between eyes.
Recommended Tests:
- HLA-B27 antigen detection, especially in patients with suspected spondyloarthropathies 3.
- Complete blood count (CBC) and erythrocyte sedimentation rate (ESR) to assess systemic inflammation 4.
- Imaging and joint assessments for signs of spondyloarthropathies 3.
Grading: Clinical grading systems like the Standardization of Uveitis Nomenclature (SUN) criteria can be applied to assess severity and guide management 5.Management
First-Line Treatment:
- Topical corticosteroids (e.g., prednisolone acetate) applied multiple times daily (typically six times/day while awake) 2.
Adjunctive Treatments:
- Biologic disease-modifying antirheumatic drugs (DMARDs) in cases with systemic involvement, particularly in patients with juvenile idiopathic arthritis 1.
- Systemic corticosteroids may be considered for refractory cases or severe inflammation 1.Special Populations
Pediatrics: Coordinated care between ophthalmology and rheumatology improves outcomes, including faster disease control 1.
Comorbidities: Patients with spondyloarthropathies, especially those with HLA-B27 positivity, require vigilant monitoring for joint involvement and systemic manifestations 3.Key Recommendations
Utilize a multidisciplinary approach, integrating rheumatology and ophthalmology, particularly in pediatric patients with anterior uveitis to enhance disease control and reduce complications (Evidence: Moderate 1).
Initiate first-line treatment with topical corticosteroids, administered frequently (e.g., six times daily), for acute anterior uveitis (Evidence: Moderate 2).
Consider HLA-B27 testing in patients with suspected spondyloarthropathy-related anterior uveitis to guide further management (Evidence: Moderate 3).
Implement evidence-based guidelines to minimize unnecessary investigations, focusing on tests with higher diagnostic yield such as CBC and ESR (Evidence: Moderate 45).References
1 Lavallee C, Ahrens M, Davidson SL, Goheer H, Shuster A, Lerman MA. Measurable Outcomes of an Ophthalmology and Rheumatology Coordinated Care Clinic. Arthritis care & research 2025. link
2 Zhang H, Nicholson CM, Kempen JH, Ying GS, Gangaputra SS. Management of Acute Non-Infectious Anterior Uveitis in Adults - Practice Patterns Among Uveitis Specialists in North America. Ocular immunology and inflammation 2025. link
3 Zheng MQ, Wang YQ, Lu XY, Wang YL, Mao LP, Gu YF et al.. Clinical analysis of 240 patients with HLA-B27 associated acute anterior uveitis. Eye science 2012. link
4 Noble J, Hollands H, Forooghian F, Yazdani A, Sharma S, Wong DT et al.. Evaluating the cost-effectiveness of anterior uveitis investigation by Canadian ophthalmologists. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2008. link
5 Forooghian F, Gupta R, Wong DT, Derzko-Dzulynsky L. Anterior uveitis investigation by Canadian ophthalmologists: insights from the Canadian National Uveitis Survey. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2006. link80026-8)
6 Ebringer R. Acute anterior uveitis and faecal carriage of gram-negative bacteria. British journal of rheumatology 1988. link